One dose of ghrelin prevents the acute and sustained increase in cardiac sympathetic tone after myocardial infarction

Endocrinology

Volumn 153, Issue 5, 2012, Pages 2436-2443

  Schwenke, Daryl O ^a   Tokudome, Takeshi ^b   Kishimoto, Ichiro ^b   Horio, Takeshi ^b   Cragg, Patricia A ^a   Shirai, Mikiyasu ^b   Kangawa, Kenji ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ELECTROPHYSIOLOGY; HEART CATHETER; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RAT; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ANIMALS; BLOOD PRESSURE; GHRELIN; HEART; HEART FAILURE; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84860351762     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2057     Document Type: Article

References (29)

1. Jardine DL, Charles CJ, Ashton RK, Bennett SI, Whitehead M, Frampton CM, Nicholls MG 2005 Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J Physiol 565:325-333 (Pubitemid 40723712)
2. Huang BS, Leenen FH 2009 The brain renin-angiotensin-aldoste rone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr Heart Fail Rep 6:81-88
3. Tsukamoto T, Morita K, Naya M, Inubushi M, Katoh C, Nishijima K, Kuge Y, Okamoto H, Tsutsui H, Tamaki N 2007 Decreased myocardial β-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy. J Nucl Med 48:1777-1782 (Pubitemid 350099321)
4. Lymperopoulos A, Rengo G, Gao E, Ebert SN, Dorn 2nd GW, Koch WJ 2010 Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and im proves cardiac function after myocardial infarction. J Biol Chem 285:16378-16386
5. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660 (Pubitemid 129516334)
6. Pusztai P, Sarman B, Ruzicska E, Toke J, Racz K, Somogyi A, Tulassay Z 2008 Ghrelin: a new peptide regulating the neurohormonal system, energy homeostasis and glucose metabolism. Diabetes Metab Res Rev 24:343-352
7. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, Hosoda H, Hirota Y, Ishida H, Mori H, Kangawa K 2001 Chronic administration ofghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104:1430-1435 (Pubitemid 32880158)
8. Nagaya N, Kangawa K 2003 Ghrelin improves left ventricular dys function and cardiac cachexia inheart failure. Curr Opin Pharmacol 3:146-151 (Pubitemid 36411238)
9. Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, Hosoda H, Kangawa K 2008 Ghrelin suppresses cardiac sympathetic activityand prevents earlyleftventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 294:H426-H432
10. Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M 2002 Central ghrelin modulates sympathetic activity in conscious rabbits. Hyper tension 40:694-699 (Pubitemid 35278606)
11. Lin Y, Matsumura K, Fukuhara M, Kagiyama S, Fujii K, Iida M 2004 Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension 43:977-982 (Pubitemid 38579901)
12. Schwenke DO, Tokudome T, Kishimoto I, Horio T, Shirai M, Cragg PA, Kangawa K 2008 Early ghrelin treatment after myocardial in farction prevents an increase in cardiac sympathetic tone and re duces mortality. Endocrinology 149:5172-5176
13. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA 2008 Measurement of cardiac function using pressure-volume conduc tance catheter technique in mice and rats. Nature Protocols 3:1422-1434
14. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E 1979 Myocardialinfarctsize andventricular function in rats. Circ Res 44:503-512
15. Schwenke DO, Tokudome T, Shirai M, Hosoda H, Horio T, Kishimoto I, Kangawa K 2008 Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats. Endocrinology 149:237-244
16. Fu LW, Longhurst JC 2009 Regulation of cardiac afferent excit ability in ischemia. In: Canning BJ, Spina D, eds. Handbook of Experimental Pharmacology. Berlin: Springer-Velag; 185-225
17. Schultz HD, Li YL 2007 Carotid body function in heart failure. Respir Physiol Neurobiol 157:171-185 (Pubitemid 46617445)
18. Liu YB, Wu CC, Lu LS, Su MJ, Lin CW, Lin SF, Chen LS, Fishbein MC, Chen PS, Lee YT 2003 Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits. Circ Res 92:1145-1152 (Pubitemid 36665861)
19. Shi Z, Chen AD, Xu Y, Chen Q, Gao XY, Wang W, Zhu GQ 2009 Long-term administration of tempol attenuates postinfarct ventric ular dysfunction and sympathetic activity inrats. Pflugers Arch 458: 247-257
20. Watson AM, Hood SG, May CN 2006 Mechanisms of sympathetic activation in heart failure. Clin Exp Pharmacol Physiol 33:1269-1274 (Pubitemid 44923921)
21. Blatnik M, Soderstrom CI 2011 A practical guide for the stabilization of acylghrelin in human blood collections. Clin Endocrinol (Oxf) 74:325-331
22. Shimizu S, Akiyama T, Kawada T, Sonobe T, Kamiya A, Shishido T, Tokudome T, Hosoda H, Shirai M, Kangawa K, Sugimachi M 2011 Centrally administered ghrelin activates cardiac vagal nerve in anesthetized rabbits. Auton Neurosci 162:60-65
23. Kishimoto I, Tokudome T, Schwenke D, Soeki T, Hosoda H, Nagaya N, Kangawa K 2009 Therapeutic potential of ghrelinincardiac diseases. Exp Rev Endocrinol Metab 4:283-289
24. Huda MS, Mani H, Dovey T, Halford JC, Boyland E, Daousi C, Wilding JP, Pinkney J 2010 Ghrelin inhibits autonomic function in healthy controls, but has no effect on obese and vagotomized subjects. Clin Endocrinol (Oxf) 73:678-685
25. Yuan MJ, Huang CX, Tang YH, Wang X, Huang H, Chen YJ, Wang T 2009 A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur J Pharmacol 618:52-57
26. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, Ueno K, Kitakaze M, Miyatake K, Kangawa K 2004 Effects of ghrelin administration on left ventricular function, exercisecapacity, and muscle wasting in patients with chronic heart failure. Circulation 110:3674-3679 (Pubitemid 39665256)
27. Andrews ZB, Erion DM, Beiler R, Choi CS, Shulman GI, Horvath TL 2010 Uncoupling protein-2 decreases the lipogenic actions of ghrelin. Endocrinology 151:2078-2086
28. Xu JP, Wang HX, Wang W, Zhang LK, Tang CS 2010 Ghrelin improves disturbed myocardial energy metabolisminrats with heart failure induced by isoproterenol. J Pept Sci 16:392-402
29. Yang B, Lin H, Xu C, Liu Y, Wang H, Han H, Wang Z 2005 Choline produces cytoprotective effects against ischemic myocardial inju ries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem 16:163-174 (Pubitemid 41643017)